Home / Japan / BrightPath Biotherapeutics Co.,Ltd.
BrightPath Biotherapeutics Co.,Ltd.
Short position disclosed on October 29, 2026. JPX register read on November 3, 2026.
Evolution of the disclosed total
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| JPM Securities Japan Co Ltd. | 0.87% | new | October 29, 2026 |
Get the moves on BrightPath Biotherapeutics Co.,Ltd. by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
Download 74 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Japan
- QD Laser,Inc. 15.12% of the capital sold short
- Datasection Inc. 12.66% of the capital sold short
- KLab Inc. 12.14% of the capital sold short
- Oncolys BioPharma Inc. 10.56% of the capital sold short
- AIMECHATEC,Ltd. 9.64% of the capital sold short
- Kyoritsu Maintenance Co.,ltd. 9.45% of the capital sold short
- SHIFT Inc. 8.79% of the capital sold short
- ReYuu Japan Inc. 8.43% of the capital sold short
- Astroscale Holdings Inc. 8.35% of the capital sold short
- Pacific Metals Co.,ltd. 7.68% of the capital sold short
- Nissan Motor Co.,ltd. 7.27% of the capital sold short
- Dynamic Map Platform Co.,Ltd. 7.23% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, BrightPath Biotherapeutics Co.,Ltd., source JPX, data as at October 29, 2026, https://www.quivad.com/action/brightpath-biotherapeutics-co-ltd
Embed the chart
<iframe src="https://www.quivad.com/embed/action/brightpath-biotherapeutics-co-ltd" width="600" height="280" title="BrightPath Biotherapeutics Co.,Ltd." loading="lazy" style="border:0"></iframe>
Badge
<a href="https://www.quivad.com/action/brightpath-biotherapeutics-co-ltd"><img src="https://www.quivad.com/action/brightpath-biotherapeutics-co-ltd/badge.svg" alt="QuiVad, BrightPath Biotherapeutics Co.,Ltd."></a>